The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Mechanism of FGF receptor dimerization and activation
Open accessAbstract
Fibroblast growth factors (fgfs) are widely believed to activate their receptors by mediating receptor dimerization. Here we show, however, that the FGF receptors form dimers in the absence of ligand, and that these unliganded dimers are phosphorylated. We further show that ligand binding triggers structural changes in the FGFR dimers, which increase FGFR phosphorylation. The observed effects due to the ligands fgf1 and fgf2 are very different. The fgf2-bound dimer structure ensures the smallest separation between the transmembrane (TM) domains and the highest possible phosphorylation, a conclusion that is supported by a strong correlation between TM helix separation in the dimer and kinase phosphorylation. The pathogenic A391E mutation in FGFR3 TM domain emulates the action of fgf2, trapping the FGFR3 dimer in its most active state. This study establishes the existence of multiple active ligand-bound states, and uncovers a novel molecular mechanism through which FGFR-linked pathologies can arise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ornitz, D. M., & Itoh, N. (2001) · Genome biology · doi:10.1186/gb-2001-2-3-reviews3005 · Cited by 2,020
Cellular signaling by fibroblast growth factor receptors
Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.001 · Cited by 1,929
Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., Eliseenkova, A. V., Yeh, B. K., Yayon, A., Linhardt, R. J., & Mohammadi, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00073-3 · Cited by 1,199
SIGNALLING BY RECEPTOR TYROSINE KINASES
Fantl, W. J., Johnson, D. E., & Williams, L. T. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002321 · Cited by 1,086
Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., & Leder, P. (1996) · Cell · doi:10.1016/s0092-8674(00)81069-7 · Cited by 1,070
The GxxxG motif: A framework for transmembrane helix-helix association
Russ, W. P., & Engelman, D. M. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3489 · Cited by 936
An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors
Burgess, A. W., Cho, H.-S., Eigenbrot, C., Ferguson, K. M., Garrett, T. P. J., Leahy, D. J., Lemmon, M. A., Sliwkowski, M. X., Ward, C. W., & Yokoyama, S. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00350-2 · Cited by 909
Structural basis for fibroblast growth factor receptor activation
Mohammadi, M., Olsen, S. K., & Ibrahimi, O. A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.008 · Cited by 735
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Turner, N., Pearson, A., Sharpe, R., Lambros, M., Geyer, F., Lopez-Garcia, M. A., Natrajan, R., Marchio, C., Iorns, E., Mackay, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3746 · Cited by 732
Spivak-Kroizman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J., & Lax, I. (1994) · Cell · doi:10.1016/0092-8674(94)90032-9 · Cited by 658
Moscatelli, D. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041310118 · Cited by 646
Chesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637
Structural Basis for FGF Receptor Dimerization and Activation
Plotnikov, A. N., Schlessinger, J., Hubbard, S. R., & Mohammadi, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80051-3 · Cited by 609
Exploring mechanisms of FGF signalling through the lens of structural biology
Goetz, R., & Mohammadi, M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3528 · Cited by 573
Chesi, M., Nardini, E., Lim, R. S. C., Smith, K. D., Kuehl, W. M., & Bergsagel, P. L. (1998) · Blood · doi:10.1182/blood.v92.9.3025 · Cited by 572
Common and Distinct Elements in Cellular Signaling via EGF and FGF Receptors
Schlessinger, J. (2004) · Science · doi:10.1126/science.1105396 · Cited by 443
Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity
Plotnikov, A. N., Hubbard, S. R., Schlessinger, J., & Mohammadi, M. (2000) · Cell · doi:10.1016/s0092-8674(00)80851-x · Cited by 407
Meyers, G. A., Orlow, S. J., Munro, I. R., Przylepa, K. A., & Jabs, E. W. (1995) · Nature Genetics · doi:10.1038/ng1295-462 · Cited by 390
Mohammadi, M., Dikic, I., Sorokin, A., Burgess, W. H., Jaye, M., & Schlessinger, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.977 · Cited by 388
ErbB receptors: new insights on mechanisms and biology
LINGGI, B., & CARPENTER, G. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.10.008 · Cited by 377
Vajo, Z., Francomano, C. A., & Wilkin, D. J. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0387 · Cited by 350
The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
Red Brewer, M., Choi, S. H., Alvarado, D., Moravcevic, K., Pozzi, A., Lemmon, M. A., & Carpenter, G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.034 · Cited by 317
FGFR activation in skeletal disorders: Too much of a good thing
Webster, M. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01131-1 · Cited by 317
A dimerization motif for transmembrane α–helices
Lemmon, M. A., Treutlein, H. R., Adams, P. D., Brünger, A. T., & Engelman, D. M. (1994) · Nature Structural Biology · doi:10.1038/nsb0394-157 · Cited by 314
FGFR2 -Amplified Gastric Cancer Cell Lines Require FGFR2 and Erbb3 Signaling for Growth and Survival
Kunii, K., Davis, L., Gorenstein, J., Hatch, H., Yashiro, M., Di Bacco, A., Elbi, C., & Lutterbach, B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5229 · Cited by 269
Role of Receptor Tyrosine Kinase Transmembrane Domains in Cell Signaling and Human Pathologies
Li, E., & Hristova, K. (2006) · Biochemistry · doi:10.1021/bi060609y · Cited by 258
Self-citationFunctions of fibroblast growth factors and their receptors
O.M. Wilkie, A., Morriss-Kay, G. M., Yvonne Jones, E., & Heath, J. K. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00102-3 · Cited by 256
Wilkie, A. O. M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.03.001 · Cited by 255
Xie, L., Su, X., Zhang, L., Yin, X., Tang, L., Zhang, X., Xu, Y., Gao, Z., Liu, K., Zhou, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3898 · Cited by 237
Cell responses to FGFR3 signalling: growth, differentiation and apoptosis
L'Hôte, C. G. M., & Knowles, M. A. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.11.012 · Cited by 218
Richelda, R., Ronchetti, D., Baldini, L., Cro, L., Viggiano, L., Marzella, R., Rocchi, M., Otsuki, T., Lombardi, L., Maiolo, A. T., et al. (1997) · Blood · doi:10.1182/blood.v90.10.4062 · Cited by 206
Evers, T. H., van Dongen, E. M. W. M., Faesen, A. C., Meijer, E. W., & Merkx, M. (2006) · Biochemistry · doi:10.1021/bi061288t · Cited by 203
Olsen, S. K., Ibrahimi, O. A., Raucci, A., Zhang, F., Eliseenkova, A. V., Yayon, A., Basilico, C., Linhardt, R. J., Schlessinger, J., & Mohammadi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307287101 · Cited by 192
Frequent FGFR3 mutations in urothelial papilloma
van Rhijn, B. W. G., Montironi, R., Zwarthoff, E. C., Jöbsis, A. C., & van der Kwast, T. H. (2002) · The Journal of Pathology · doi:10.1002/path.1202 · Cited by 189
RTK mutations and human syndromes: when good receptors turn bad
Robertson, S. C., Tynan, J., & Donoghue, D. J. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02077-1 · Cited by 168
Transmembrane helix dimerization: Beyond the search for sequence motifs
Li, E., Wimley, W. C., & Hristova, K. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.08.031 · Cited by 164
Self-citationInhibition of Basal FGF Receptor Signaling by Dimeric Grb2
Lin, C., Melo, F. A., Ghosh, R., Suen, K. M., Stagg, L., Kirkpatrick, J., Arold, S. T., Ahmed, Z., & Ladbury, J. E. (2012) · Cell · doi:10.1016/j.cell.2012.04.033 · Cited by 156
van Rhijn, B. V., van Tilborg, A. V., Lurkin, I., Bonaventure, J., de Vries, A., Thiery, J., van der Kwast, T., Zwarthoff, E., & Radvanyi, F. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200883 · Cited by 155
RTK mutations and human syndromes
Robertson, S. C., Tynan, J. A., & Donoghue, D. J. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(00)02021-7 · Cited by 143
Rotational Coupling of the Transmembrane and Kinase Domains of the Neu Receptor Tyrosine Kinase
Bell, C. A., Tynan, J. A., Hart, K. C., Meyer, A. N., Robertson, S. C., & Donoghue, D. J. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.10.3589 · Cited by 141
Takeda, M., Arao, T., Yokote, H., Komatsu, T., Yanagihara, K., Sasaki, H., Yamada, Y., Tamura, T., Fukuoka, K., Kimurâ, H., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2743 · Cited by 136
Measuring the Energetics of Membrane Protein Dimerization in Mammalian Membranes
Chen, L., Novicky, L., Merzlyakov, M., Hristov, T. S., & Hristova, K. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910692u · Cited by 131
Self-citationSequence Context Modulates the Stability of a GxxxG-mediated Transmembrane Helix–Helix Dimer
Doura, A. K., Kobus, F. J., Dubrovsky, L., Hibbard, E., & Fleming, K. G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.042 · Cited by 104
Grb2, a Double-Edged Sword of Receptor Tyrosine Kinase Signaling
Belov, A. A., & Mohammadi, M. (2012) · Science Signaling · doi:10.1126/scisignal.2003576 · Cited by 103
The FRET Signatures of Noninteracting Proteins in Membranes: Simulations and Experiments
King, C., Sarabipour, S., Byrne, P. O., Leahy, D. J., & Hristova, K. A. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.01.039 · Cited by 95
Self-citationGrb2 controls phosphorylation of FGFR2 by inhibiting receptor kinase and Shp2 phosphatase activity
Ahmed, Z., Lin, C., Suen, K. M., Melo, F. A., Levitt, J. A., Suhling, K., & Ladbury, J. E. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201204106 · Cited by 91
Piccolo, N. D., Placone, J. K., He, L., Agudelo, S. C., & Hristova, K. A. (2012) · Analytical Chemistry · doi:10.1021/ac301776j · Cited by 87
Self-citationSome chondrodysplasias with short limbs: Molecular perspectives
Cohen, M. M. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10780 · Cited by 71
Chen, L., Placone, J. K., Novicky, L., & Hristova, K. A. (2010) · Science Signaling · doi:10.1126/scisignal.2001195 · Cited by 57
Self-citationBryant, M., Marta, C. B., Kim, F. S., & Bansal, R. (2008) · Glia · doi:10.1002/glia.20818 · Cited by 54
Sarabipour, S., Piccolo, N. D., & Hristova, K. A. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00238 · Cited by 54
Self-citationDirect binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function.
Ahmed, Z., George, R., Lin, C.-C., Suen, K. M., Levitt, J., Suhling, K., & Ladbury, J. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.08.011 · Cited by 43
Quantitative Measurements of Protein Interactions in a Crowded Cellular Environment
Li, E., Placone, J. K., Merzlyakov, M., & Hristova, K. A. (2008) · Analytical Chemistry · doi:10.1021/ac800616u · Cited by 43
Self-citationFGFR3 Unliganded Dimer Stabilization by the Juxtamembrane Domain
Sarabipour, S., & Hristova, K. A. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.02.013 · Cited by 36
Self-citationSarabipour, S., & Hristova, K. A. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.03.022 · Cited by 35
Self-citationThe Physical Basis of FGFR3 Response to fgf1 and fgf2
Chen, F., & Hristova, K. A. (2011) · Biochemistry · doi:10.1021/bi200986f · Cited by 26
Self-citationSarabipour, S., Chan, R., Zhou, B., Paolo, G. D., & Hristova, K. A. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.04.002 · Cited by 26
Self-citationMultiple Consequences of a Single Amino Acid Pathogenic RTK Mutation: The A391E Mutation in FGFR3
Chen, F., Sarabipour, S., & Hristova, K. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056521 · Cited by 16
Self-citationBiologists abandon Popper at their peril
(2000) · doi:10.1002/(sici)1521-1878(200002)22:2
Cited by
FGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration
Farooq, M., Khan, A. W., Kim, M. S., & Choi, S. (2021) · Cells · doi:10.3390/cells10113242 · Cited by 346
Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer
Raoof, S., Mulford, I. J., Frisco-Cabanos, H., Nangia, V., Timonina, D., Labrot, E., Hafeez, N., Bilton, S. J., Drier, Y., Ji, F., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0887-2 · Cited by 216
Metadata
- Authors
- Sarabipour, S., & Hristova, K.
- Venue
- Nature Communications
- Published
- 2016-01-04
- Volume
- 7
- Issue
- 1
- Pages
- 10262-10262
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2229729310
- Cited by
- 255
- References
- 59
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.